AU742824C - Use of neuro-derived fetal cell lines for transplantation therapy - Google Patents

Use of neuro-derived fetal cell lines for transplantation therapy

Info

Publication number
AU742824C
AU742824C AU25182/00A AU2518200A AU742824C AU 742824 C AU742824 C AU 742824C AU 25182/00 A AU25182/00 A AU 25182/00A AU 2518200 A AU2518200 A AU 2518200A AU 742824 C AU742824 C AU 742824C
Authority
AU
Australia
Prior art keywords
neuro
cell lines
fetal cell
transplantation therapy
derived fetal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25182/00A
Other versions
AU742824B2 (en
AU2518200A (en
Inventor
Eugene MAJOR
Carlo Tornatore
Gal Yadid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU60363/96A external-priority patent/AU6036396A/en
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Priority to AU25182/00A priority Critical patent/AU742824C/en
Publication of AU2518200A publication Critical patent/AU2518200A/en
Application granted granted Critical
Publication of AU742824B2 publication Critical patent/AU742824B2/en
Publication of AU742824C publication Critical patent/AU742824C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU25182/00A 1995-06-06 2000-03-31 Use of neuro-derived fetal cell lines for transplantation therapy Ceased AU742824C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU25182/00A AU742824C (en) 1995-06-06 2000-03-31 Use of neuro-derived fetal cell lines for transplantation therapy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US467958 1995-06-06
AU60363/96A AU6036396A (en) 1995-06-06 1996-06-06 Use of neuro-derived fetal cell lines for transplantation therapy
AU25182/00A AU742824C (en) 1995-06-06 2000-03-31 Use of neuro-derived fetal cell lines for transplantation therapy

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU60363/96A Division AU6036396A (en) 1995-06-06 1996-06-06 Use of neuro-derived fetal cell lines for transplantation therapy

Publications (3)

Publication Number Publication Date
AU2518200A AU2518200A (en) 2000-06-22
AU742824B2 AU742824B2 (en) 2002-01-10
AU742824C true AU742824C (en) 2003-03-20

Family

ID=3745459

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25182/00A Ceased AU742824C (en) 1995-06-06 2000-03-31 Use of neuro-derived fetal cell lines for transplantation therapy

Country Status (1)

Country Link
AU (1) AU742824C (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707448A (en) * 1984-10-04 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Immortal line of human fetal glial cells
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
WO1994023754A1 (en) * 1993-04-13 1994-10-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of neuro-derived fetal cell lines for transplantation therapy

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4707448A (en) * 1984-10-04 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Immortal line of human fetal glial cells
US5082670A (en) * 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
WO1994023754A1 (en) * 1993-04-13 1994-10-27 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of neuro-derived fetal cell lines for transplantation therapy

Also Published As

Publication number Publication date
AU742824B2 (en) 2002-01-10
AU2518200A (en) 2000-06-22

Similar Documents

Publication Publication Date Title
HUP9900899A3 (en) Use of neuro-derived fetal cell lines for transplantation therapy
AU4282996A (en) Mesoscale devices for analysis of motile cells
AU5930396A (en) Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
AU7612196A (en) Functional human hematopoietic cells
AU698498B2 (en) Tissue culture flask
AU3034695A (en) Single well system for mapping sources of acoustic energy
AU2650795A (en) Methods and apparatus for cryopreservation of cells
AU5429196A (en) Cryopreservation of cell suspensions
AU4754393A (en) Cell culture insert
AU5268696A (en) Novel compounds and methods for therapy
AU5596896A (en) Container for wetted tissues
AU4754493A (en) Cell culture insert
AU1119397A (en) Ex vivo culture of stem cells
AU3683895A (en) Artificial organ culture system
AU5788396A (en) Methods of inhibition or killing of cancer cells
AU5064196A (en) Photochemical cell
AU3609693A (en) Method of assaying for the oncogenic state of cells
AU4788993A (en) Use of pouch for implantation of living cells
AU3557597A (en) The isolation and culture of fetal cells from peripheral maternal blood
AU1868195A (en) Cell signaling inhibitors
AU7312196A (en) Synthesis of polymerisable phosphodiesters
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU3455393A (en) Preparation for skin use
AU6130196A (en) Cell treatment
AU3586595A (en) Preparation of immortalized cells

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20011224

FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20020124

DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20020820

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20020912